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Cystic ﬁbrosis (CF) is an inﬂammatory and destructive disease with differenti-
ated clinical expression. Conducted studies revealed the presence of vitamin K
deﬁciencies. However, available results in infants and young children are limited.
Therefore, the aim of the present study has been to assess vitamin K status in young
CF patients.
Material and Methods: Twelve CF infants aged up to 12 months were introduced
into the study. Uncarboxylated prothrombin concentrations (Prothrombin Induced
by Vitamin K Absence − PIVKA II) as vitamin K deﬁciency index were mea-
sured (ELISA) in all subjects. In addition, nutritional status (standardized body
weight), exocrine pancreatic function (fecal elastase-1 concentrations), expression
of bronchopulmonary disease and vitamin K dosage were also assessed.
Results: All subjects were pancreatic insufﬁcient, pulmonary manifestation was
differentiated. In a signiﬁcant percentage of CF patients body weight deﬁcit
was present at diagnosis. Eight children received vitamin K preparations in a
dose 0.025−0.4mg/day. In ﬁve children receiving supplementation and two non-
supplemented subjects PIVKA II was detectable (range 3.1 to 97 ng/mL). No sig-
niﬁcant correlation between PIVKA II levels and values of classic (r = −0.468) and
conductometric (r = −0.454) sweat test, standardized body weight (r = 0.186), fecal
elastase-1 concentrations (r = 0.116), vitamin K supplementation dose (r = 0.334)
and the expression of bronchopulmonary disease (r = −0.230) was stated.
Conclusions: Vitamin K deﬁciency seems to be present in cystic ﬁbrosis patients
from infancy. No correlation between PIVKA II and parameters assessing the
intensity of the disease has been stated.
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Predictors of vitamin K status were examined in 8- to 25-yr old subjects with cystic
ﬁbrosis (CF) and pancreatic insufﬁciency (PI). Growth status, genotype, pulmonary
function, serum vitamin D, dietary intake, vitamin K supplemental intake, and serum
undercarboxylated osteocalcin as % total osteocalcin (%ucOC) were assessed.
Sufﬁcient vitamin K status was deﬁned as %ucOC< 20%. Subjects were divided
into 3 vitamin K supplementation groups: <150 ug/d (low; multivitamins/no sup-
plement), 150–999 ug/d (mid; CF-speciﬁc vitamin preparations), and 1000 ug/d
(high; mephyton). Vitamin K supplementation (median intake 300 mg/day) and
%ucOC (34±18%) were negatively associated (r = −0.55, P< 0.001). Only subjects
in the high supplemental intake group achieved a sufﬁcient vitamin K status
(22±16) compared to the mid (38±16) and low (45±14) groups (both P< 0.001,
high vs. mid and high vs. low). Age, gender, vitamin K supplementation group, and
vitamin D were signiﬁcant predictors of vitamin K status, together explaining 43%
of the variance in vitamin K status. By gender, vitamin K supplementation group
for both males and females, in addition to vitamin D and a trend for age in males
were signiﬁcant predictors of vitamin K status together explained 31 and 54% of
the variance in vitamin K status in males and females, respectively. In conclusion,
only vitamin K supplementation dose predicts vitamin K status for both males and
females with CF and PI, thus highlighting the importance of routine high dose
vitamin K supplementation for this population.
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Background: Increased oxidative stress is well known in Cystic Fibrosis (CF)
patients. Studies still address the question if CF patients need higher antioxidant
plasma concentrations than healthy subjects.
Objective: To assess if “normal” values of plasma antioxidants counterbalance
adequately oxidative stress in stable CF patients with or w/o pancreatic insufﬁciency
(p.i).
70 patients were recruited during a routine visit in our CF Regional Center
(32M/38F, median age 7.8, 36/70 with p.i.) whose 91% with vitamin supple-
mentation. Red-ox status as: plasma or erythrocytes antioxidants: vit. E, A, C,
selenium (Se), reduced (GSH) and oxidised (GSSG) glutathione, GSHPx; lipid
oxidation markers: chromolipids (MDA and HNE aldehydes).
Results: The majority of patients (>87%) showed normal concentrations of vit E,
A, C and Se (local reference range). Similarly GSH and GSHPx erythrocyte levels
were normal (>74%). Actually normal chromolipid levels were found in only 2−6%
and 94% of patients showed low GSH/GSSG ratio. CF patients with p.i. showed
signiﬁcantly higher HNE- and MDA-chromolipid levels, despite the absence of
steatorrhea and no signiﬁcant differences in vitamin concentrations. Independently
from other viariables, signiﬁcant correlations were found between age and vitamin E
and C concentrations (inverse), and MDA, HNE chromolipids (direct) and between
antioxidants and MDA or HNE chromolipids (inverse).
Conclusions: “Normal” antioxidant plasma levels do not provide adequate control
on oxidative stress markers that are directly correlated with aging, pancreatic
insufﬁciency and indirectly correlated with plasma levels of antioxidant vitamins.
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When reviewing annual review results we found that of our CF patients had normal
Hb but that majority had a low RBC mean cell volume (MCV) a feature which is
seen in iron deﬁciency. We therefore started to measure serum ferritin as a measure
of iron status at annual review and assessing the iron intake of patients from their
3 day food diaries.
Method: Latest annual review FBC and ferritin results and analysed food diaries
(where available) were studied. Information on whether the child was on iron
supplements was obtained from notes.
Results: Latest annual reviews of 34 CF patients (aged 1 to 15 years) were looked
at. 32/34 were pancreatic insufﬁcient. FBC available for all, serum ferritin for
24 and analysed completed food diaries for 15. 4 patients were already on iron
supplements (started previously for low iron intake). Mean Hb was 13.4 g/dl, mean
MCV 79.5 ﬂ. MCV for those not on iron supplements were lower (79.4) than those
on iron supplements (80.3). Ferritin levels for patients not on iron supplements
(21/24) were low (mean 26 ng/ml) compared with those on iron supplements (mean
145 ng/ml). Dietary iron intake was above recommended in majority (12/15). 2 out
of the 3 patients with low dietary iron intake were already on iron supplements.
7 further patients were started on iron supplements following their annual review
as their ferritin was low (mean 21.3 ng/ml).
Conclusion: Serum ferritin levels of our paediatric CF patients which are not on
iron supplements are low despite adequate iron intake suggesting a possible problem
with iron absorption. Iron supplementation results in a rise in ferritin levels but is
this of any clinical signiﬁcance?
